Welcome to the international HTA database

Showing [23734 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2007	NIHR Health Technology Assessment programme	Strontium ranelate for the prevention of osteoporotic fractures in post-menopausal women with osteoporosis
2008	NIHR Health Technology Assessment programme	Structural brain imaging in first episode psychosis
2008	Quality Improvement Scotland (NHS QIS )	Structural neuroimaging in first episode psychosis
2008	National Institute for Health and Care Excellence (NICE)	Structural neuroimaging in first-episode psychosis. NICE technology appraisal guidance 136
2008	NIHR Health Technology Assessment programme	Structural neuroimaging in psychosis: a systematic review and economic evaluation
2018	Health Quality Ontario (HQO)	Structured Education and Neuromuscular Exercise Program for Hip and/or Knee Osteoarthritis: A Health Technology Assessment
2018	NIHR Health Technology Assessment programme	Structured lifestyle education to support weight loss for people with schizophrenia, schizoaffective disorder and first episode psychosis: the STEPWISE RCT
2022	Penn Medicine Center for Evidence-based Practice (CEP)	Structured screening questionnaires for alcohol misuse/alcohol use disorders
2015	NIHR Health Technology Assessment programme	Structured telephone support or telemonitoring programmes for patients with chronic heart failure
2014	NIHR Health Technology Assessment programme	Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation the CASCADE study
2002	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	Studies and scales used in technologies within the orthoprosthetic benefits. IPE-02/33 (Public report)
2013	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	Study of adherence to Recombinant Growth Hormone treatment of children with a GH deficiency: contributions to treatment control and economic impact
1999	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	Study of the appropriateness of prescribing antibiotic treatments in primary care and costs derived from inappropriateness
2004	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	Study of the factors that may explain the differences in population prevalence and in hospitalised patients due to mental disorders by territory
2013	NIHR Health Technology Assessment programme	Study of the use of antidepressants for depression in dementia: the HTA -SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine
1998	TNO	Study of waiting lists in mental primary care (AGGZ)
2005	Agency for Healthcare Research and Quality (AHRQ)	Study on Regulation of Health Care: The Impact of Regulation on the Health Insurance Market and Health Care Providers
2005	NIHR Horizon Scanning Centre (NIHR HSC)	SU11248 for 2nd-line treatment of gastrointestinal stromal tumour (GIST) in patients refractory or intolerant of imatinib mesylate - horizon scanning review
2005	NIHR Horizon Scanning Centre (NIHR HSC)	SU11248 for metastatic renal cell carcinoma (Stage IV) - horizon scanning review
2021	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Subacromial decompression as a primary/isolated intervention to treat subacromial pain
2021	Swiss Federal Office of Public Health (FOPH)	Subacromial decompression as a primary/isolated intervention to treat subacromial pain
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Subacromial decompression for rotator cuff disease
2021	Norwegian Institute of Public Health (NIPH)	Subacromial decompression surgery for impingement syndrome: rapid health technology assessment
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Subcutaneous administration of proton pump inhibitors in palliative care patients: a review of clinical effectiveness and guidelines
2018	National Institute for Health and Care Excellence (NICE)	Subcutaneous automated low-flow pump implantation for refractory ascites caused by cirrhosis. NICE interventional procedures guidance 631
2012	Medical Services Advisory Committee (MSAC)	Subcutaneous Immunoglobulins (SCIg)
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Subcutaneous immunotherapy for the treatment of allergies: a review of the clinical efficacy, safety and guidelines
2018	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Subcutaneous implantable cardioverter defibrillator (ICD)
2017	HAYES, Inc.	Subcutaneous implantable cardioverter defibrillator (S-ICD) for prevention of sudden cardiac death
2017	National Institute for Health and Care Excellence (NICE)	Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death. NICE interventional procedures guidance 603
2010	Adelaide Health Technology Assessment (AHTA)	Subcutaneous implantable cardioverter-defibrillator (ICD) for patients at risk of sudden cardiac death
2022	Austrian Institute for Health Technology Assessment (AIHTA)	Subcutaneous implantable cardioverter-defibrillator (S-ICD). Update 2022
2010	HAYES, Inc.	Subcutaneous implantation of estradiol pellets for postmenopausal disorders
2011	HAYES, Inc.	Subcutaneous implantation of estradiol pellets for postmenopausal disorders
2012	HAYES, Inc.	Subcutaneous implantation of estradiol pellets for postmenopausal disorders
2017	NIHR Health Technology Assessment programme	Subcutaneous Injection of Adalimumab Trial compared with Control (SCIATiC): a randomised controlled trial of adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Subcutaneous lidocaine in community care: a review of the guidelines and patient safety
2007	Canadian Agency for Drugs and Technologies in Health (CADTH)	Subcutaneous open-loop insulin delivery for type 1 diabetes: Paradigm (TM) real-time system
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Subcutaneous tocilizumab for juvenile idiopathic polyarthritis – second line
2008	Canadian Agency for Drugs and Technologies in Health (CADTH)	Subcutaneous versus intravenous immunoglobulin for primary immunodeficiencies: systematic review and economic evaluation
2004	National Institute for Health and Care Excellence (NICE)	Subfascial endoscopic perforator vein surgery. NICE interventional procedures guidance 59
2011	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Subglottic secretion drainage endotracheal tubes for prevention of ventilator-associated pneumonia
2001	NIHR Health Technology Assessment programme	Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives
2022	Malaysian Health Technology Assessment (MaHTAS)	Sublingual immunotherapy (SLIT) for atopy (allergic rhinitis, eczema and asthma)
2003	Blue Cross Blue Shield Association (BCBS)	Sublingual immunotherapy for adults
2011	HAYES, Inc.	Sublingual immunotherapy for allergic rhinitis
2009	HAYES, Inc.	Sublingual immunotherapy for allergic rhinitis and asthma
2004	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Submandibular gland transfer for preservation of salivary function
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suboxone for short-term detoxification: a review of the clinical evidence
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suboxone for the treatment of chronic non-cancer pain: clinical effectiveness and guidelines
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suboxone versus methadone for the detoxification of patients addicted to prescription opioids: a review of comparative clinical effectiveness, safety, and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suboxone versus methadone for the treatment of opioid dependence: a review of the clinical and cost-effectiveness
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Subsequent entry biologics — emerging trends in regulatory and health technology assessment frameworks
2017	Adelaide Health Technology Assessment (AHTA)	Substitution of 68-Ga-DOTA-peptide PET/CT scanning in lieu of Octreotide for patients undergoing somatostatin receptor diagnostic imaging under MBS item 61369
2012	HAYES, Inc.	Subtalar arthroereisis for the treatment of flatfoot
2009	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Subthalamic deep brain stimulation (DBS): clinical efficacy, safety and cost compared to medical therapy for the treatment of Parkinson's Disease
2004	National Institute for Health and Care Excellence (NICE)	Subthalamotomy for Parkinson's disease. NICE interventional procedures guidance 65
2003	Wessex Institute for Health Research and Development (WIHRD)	Successive attempts at in vitro fertilization
2015	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Sucroferric oxyhydroxide (Velphoro®)
2024	Ontario Health	Sucrose octosulfate (SOS)-impregnated dressings for adults with difficult-to-heal noninfected diabetic foot ulcers and difficult-to-heal noninfected venous leg ulcers
2009	National Institute for Health and Care Excellence (NICE)	Suction diathermy adenoidectomy. NICE interventional procedures guidance 328
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suctioning for respiratory blockage: clinical effectiveness and guidelines
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suctioning for respiratory blockage: clinical effectiveness and guidelines
2006	NIHR Horizon Scanning Centre (NIHR HSC)	Sugammadex (Org 25969) for reversal of muscle relaxation in general anaesthesia: horizon scanning technology briefing
2010	NIHR Health Technology Assessment programme	Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment
2003	Alberta Heritage Foundation for Medical Research (AHFMR)	Suicide prevention strategies: evidence from systematic reviews
2017	Agency for Care Effectiveness (ACE)	Sumatriptan for the treatment of acute migraine attacks
2007	NIHR Horizon Scanning Centre (NIHR HSC)	Sunitinib (Sutent) for advanced and/or metastatic breast cancer
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Sunitinib (Sutent) for locally advanced and/or metastatic non-small cell lung cancer - second line
2011	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Sunitinib (Sutent®)
2007	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Sunitinib (Sutent®)
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Sunitinib for advanced and/or metastatic pancreatic neuroendocrine tumours
2009	National Institute for Health and Care Excellence (NICE)	Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma. NICE technology appraisal guidance 169
2006	Institute for Clinical Effectiveness and Health Policy (IECS)	Sunitinib for the management of renal cell carcinoma
2008	Institute for Clinical Effectiveness and Health Policy (IECS)	Sunitinib for the management of renal cell carcinoma
2009	NIHR Health Technology Assessment programme	Sunitinib for the treatment of gastrointestinal stromal tumours: a critique of the submission from Pfizer
2009	National Institute for Health and Care Excellence (NICE)	Sunitinib for the treatment of gastrointestinal stromal tumours. NICE technology appraisal guidance 179
2007	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	Sunitinib in metastatic renal-cell cancer: efficacy and safety
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Sunitinib malate (Sutent) for renal cell carcinoma – adjuvant therapy
2022	National Institute for Health and Care Excellence (NICE)	Supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis. NICE interventional procedures guidance 726
2014	HAYES, Inc.	Superficial inferior epigastric artery (SIEA) flap procedure for postmastectomy breast reconstruction
2022	National Institute for Health and Care Excellence (NICE)	Superficial venous arterialisation for chronic limb threatening ischaemia. NICE interventional procedures guidance 736
2018	National Institute for Health and Care Excellence (NICE)	Superior capsular augmentation for massive rotator cuff tears. NICE interventional procedures guidance 619
2018	National Institute for Health and Care Excellence (NICE)	Superior rectal artery embolisation for haemorrhoids. NICE interventional procedures guidance 627
1996	Australian Health Technology Advisory Committee (AHTAC)	Superspeciality service guidelines for adult heart transplantation services
1995	Australian Health Technology Advisory Committee (AHTAC)	Superspecialty service guidelines for acute cardiac interventions
1999	Australian Health Technology Advisory Committee (AHTAC)	Superspecialty service guidelines for haemopoietic stem cell transplantation (WITHDRAWN)
1998	Australian Health Technology Advisory Committee (AHTAC)	Superspecialty service guidelines for lung transplantation services
1995	Australian Health Technology Advisory Committee (AHTAC)	Superspecialty services guidelines for heart transplantation
1995	Australian Health Technology Advisory Committee (AHTAC)	Superspecialty services guidelines for liver transplantation
2020	Institute for Clinical and Economic Review (ICER)	Supervised injection facilities and other supervised consumption sites: effectiveness and value
2003	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	Supervised use of artificial anal sphincter - database and technology assessment. IPE-03/k
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Supplemental oxygen therapy for patients with acute myocardial infarction
2017	Agency for Healthcare Research and Quality (AHRQ)	Supplemental project to assess the transparency of reporting for strategies to improve mental health care for children and adolescents
2017	Agency for Healthcare Research and Quality (AHRQ)	Supplemental project to assess the transparency of reporting requirements for studies evaluating the effectiveness of treatment options for symptoms of diabetic peripheral neuropathy
2023	Ontario Health	Supplemental Screening as an Adjunct to Mammography for Breast Cancer Screening in People With Dense Breasts
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Supplementary feedings for healthy breastfed full-term infants
2004	NIHR Health Technology Assessment programme	Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis
2017	NIHR Health Technology Assessment programme	Support and Assessment for Fall Emergency Referrals (SAFER) 2: a cluster randomised trial and systematic review of clinical effectiveness and cost-effectiveness of new protocols for emergency ambulance paramedics to assess older people following a fall with referral to community-based care when appropriate
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Support for 'second victims' in the acute care setting